TY - JOUR
T1 - Long-term Risks of Depression and Suicide Among Men with Prostate Cancer
T2 - A National Cohort Study
AU - Crump, Casey
AU - Stattin, Pär
AU - Brooks, James D.
AU - Sundquist, Jan
AU - Bill-Axelson, Anna
AU - Edwards, Alexis C.
AU - Sundquist, Kristina
AU - Sieh, Weiva
N1 - Funding Information:
Acknowledgments: This project was made possible by the continuous work of the National Prostate Cancer Register of Sweden steering group: David Robinson (register holder), Ingela Franck Lissbrant (chair), Johan Styrke (co-chair), Johan Stranne, Jon Kindblom, Camilla Thellenberg, Andreas Josefsson, Ingrida Verbiene, Hampus Nugin, Stefan Carlsson, Anna Kristiansen, Mats Andén, Thomas Jiborn, Olof Ståhl, Olof Akre, Per Fransson, Eva Johansson, Magnus Törnblom, Fredrik Jäderling, Marie Hjälm Eriksson, Lotta Renström, Jonas Hugosson, Ola Bratt, Maria Nyberg, Fredrik Sandin, Camilla Byström, Mia Brus, Mats Lambe, Anna Hedström, Nina Hageman, Christofer Lagerros, and the patient representatives Hans Joelsson and Gert Malmberg.
Funding Information:
Funding/Support and role of the sponsor: This work was supported by the National Cancer Institute (R01 CA269553 to C.C., K.S., and W.S.); the National Institute on Alcohol Abuse and Alcoholism (R01 AA027522 to A.C.E. and K.S.) at the National Institutes of Health; the Swedish Research Council; and an ALF project grant (Region Skåne/Lund University, Sweden). The funding agencies had no direct role in the study.
Publisher Copyright:
© 2023 European Association of Urology
PY - 2023
Y1 - 2023
N2 - Background: A diagnosis of prostate cancer (PC) may cause psychosocial distress that worsens quality of life; however, long-term mental health outcomes are unclear. Objective: To determine the long-term risks of major depression and death by suicide in a large population-based cohort. Design, setting, and participants: This was a national cohort study of 180 189 men diagnosed with PC during 1998–2017 and 1 801 890 age-matched, population-based, control men in Sweden. Outcome measurements and statistical analysis: Major depression and death by suicide were ascertained from nationwide outpatient, inpatient, and death records up to 2018. Cox regression was used to compute hazard ratios (HRs) adjusted for sociodemographic factors and comorbidities. Subanalyses assessed differences by PC treatment during 2005–2017. Results and limitations: Men diagnosed with high-risk PC had higher relative rates of major depression (adjusted HR [aHR] 1.82, 95% confidence interval [CI] 1.75–1.89) and death by suicide (aHR 2.43, 95% CI 2.01–2.95). These associations persisted for ≥10 yr after PC diagnosis. The relative increase in major depression was lower among those treated with radiation (aHR 1.44, 95% CI 1.31–1.57) or surgery (aHR 1.60, 95% CI 1.31–1.95) in comparison to androgen deprivation therapy (ADT) alone (aHR 2.02, 95% CI 1.89–2.16), whereas the relative rate of suicide death was higher only among those treated solely with ADT (aHR 2.83, 95% CI 1.80–4.43). By contrast, men with low- or intermediate-risk PC had a modestly higher relative rate of major depression (aHR 1.19, 95% CI 1.16–1.23) and higher relative rate of suicide death at 3–12 mo after PC diagnosis (aHR 1.88, 95% CI 1.11–3.18) but not across the entire follow-up period (aHR 1.02, 95% CI 0.84–1.25). This study was limited to Sweden and will need replication in other populations. Conclusions: In this large cohort, high-risk PC was associated with substantially higher relative rates of major depression and death by suicide, which persisted for ≥10 yr after PC diagnosis. PC survivors need close follow-up for timely detection and treatment of psychosocial distress. Patient summary: In a large Swedish population, men with aggressive prostate cancer had higher long-term relative rates of depression and suicide.
AB - Background: A diagnosis of prostate cancer (PC) may cause psychosocial distress that worsens quality of life; however, long-term mental health outcomes are unclear. Objective: To determine the long-term risks of major depression and death by suicide in a large population-based cohort. Design, setting, and participants: This was a national cohort study of 180 189 men diagnosed with PC during 1998–2017 and 1 801 890 age-matched, population-based, control men in Sweden. Outcome measurements and statistical analysis: Major depression and death by suicide were ascertained from nationwide outpatient, inpatient, and death records up to 2018. Cox regression was used to compute hazard ratios (HRs) adjusted for sociodemographic factors and comorbidities. Subanalyses assessed differences by PC treatment during 2005–2017. Results and limitations: Men diagnosed with high-risk PC had higher relative rates of major depression (adjusted HR [aHR] 1.82, 95% confidence interval [CI] 1.75–1.89) and death by suicide (aHR 2.43, 95% CI 2.01–2.95). These associations persisted for ≥10 yr after PC diagnosis. The relative increase in major depression was lower among those treated with radiation (aHR 1.44, 95% CI 1.31–1.57) or surgery (aHR 1.60, 95% CI 1.31–1.95) in comparison to androgen deprivation therapy (ADT) alone (aHR 2.02, 95% CI 1.89–2.16), whereas the relative rate of suicide death was higher only among those treated solely with ADT (aHR 2.83, 95% CI 1.80–4.43). By contrast, men with low- or intermediate-risk PC had a modestly higher relative rate of major depression (aHR 1.19, 95% CI 1.16–1.23) and higher relative rate of suicide death at 3–12 mo after PC diagnosis (aHR 1.88, 95% CI 1.11–3.18) but not across the entire follow-up period (aHR 1.02, 95% CI 0.84–1.25). This study was limited to Sweden and will need replication in other populations. Conclusions: In this large cohort, high-risk PC was associated with substantially higher relative rates of major depression and death by suicide, which persisted for ≥10 yr after PC diagnosis. PC survivors need close follow-up for timely detection and treatment of psychosocial distress. Patient summary: In a large Swedish population, men with aggressive prostate cancer had higher long-term relative rates of depression and suicide.
KW - Depression
KW - Prostate cancer
KW - Prostatic neoplasms
KW - Suicide
UR - http://www.scopus.com/inward/record.url?scp=85158828231&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2023.04.026
DO - 10.1016/j.eururo.2023.04.026
M3 - Article
AN - SCOPUS:85158828231
SN - 0302-2838
JO - European Urology
JF - European Urology
ER -